Fletikumab
CAS No. 1357158-22-5
Fletikumab ( —— )
产品货号. M36697 CAS No. 1357158-22-5
Fletikumab (NNC0109-0012) 是一种靶向 IL-20 的单克隆抗体。Fletikumab 可用于炎症研究,如类风湿关节炎。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥4238 | 有现货 |
|
| 5MG | ¥6428 | 有现货 |
|
| 10MG | ¥8802 | 有现货 |
|
| 25MG | ¥12903 | 有现货 |
|
| 50MG | ¥17360 | 有现货 |
|
| 100MG | ¥22415 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Fletikumab
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Fletikumab (NNC0109-0012) 是一种靶向 IL-20 的单克隆抗体。Fletikumab 可用于炎症研究,如类风湿关节炎。
-
产品描述Fletikumab (NNC0109-0012) is a monoclonal antibody targeting to IL-20. Fletikumab can be used for inflammation research, such as rheumatoid arthritis.
-
体外实验Fletikumab blocks IL-20 binding IL-20 receptor, acts potential function of inflammation inhibition.IL-20 is a member of IL-10 family, which includes IL-10, IL-19, IL-22, IL-24, IL-26, IL-28, and IL-29. IL-20 acts on renal cells and contributes to inflammation, fibrosis, and apoptosis through its receptors IL-20R1, IL-20R2, and IL-22R1.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Interleukin
-
研究领域——
-
适应症——
化学信息
-
CAS Number1357158-22-5
-
分子量
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Kragstrup TW, et al. The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis. Front Immunol. 2018 Sep 25;9:2226.? ?
产品手册
关联产品
-
AA41612
AA41612 是一种新型黑视蛋白介导的光转导拮抗剂。
-
Isomartynoside
Isomartynoside has inhibition against the angiotensin converting enzyme (ACE) activities, the IC 50 value is 505±26.7μg/ml, it may have antihypertensive effect. Isomartynoside also shows obvious anti-fatigue activity.
-
[Gly22] -β- Amyloid ...
[Gly22] -β- Amyloid (1 - 40)
021-51111890
购物车()
sales@molnova.cn

